Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

KLRS US Equity

Kalaris Therapeutics, Inc.Health Care · Biological Products, (No Diagnostic Substances) · CIK 1754068 · FY ends Dec 31
$4.15
+0.03 (+0.73%)
USD · as of 2026-08-21 · marketstack
DateEventWhat happened / filerSource
2026-08-118-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-07-208-K 5.02Departure/election of directors or officers; compensationsec.gov ↗
2026-07-178-K 8.01Other eventssec.gov ↗
2026-07-178-K 7.01Regulation FD disclosuresec.gov ↗
2026-07-068-K 5.02Departure/election of directors or officers; compensationsec.gov ↗
Source: SEC EDGAR (public domain) · history starts 2026-07-06

Every row is a filed document, checked against its EDGAR index.